These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19375659)

  • 1. What's the FUS!
    Traynor BJ; Singleton AB
    Lancet Neurol; 2009 May; 8(5):418-9. PubMed ID: 19375659
    [No Abstract]   [Full Text] [Related]  

  • 2. No effect on SOD1 splicing by TARDP or FUS mutations.
    Belzil VV; Daoud H; Dion PA; Rouleau GA
    Arch Neurol; 2011 Mar; 68(3):395-6. PubMed ID: 21403029
    [No Abstract]   [Full Text] [Related]  

  • 3. Optineurin is co-localized with FUS in basophilic inclusions of ALS with FUS mutation and in basophilic inclusion body disease.
    Ito H; Fujita K; Nakamura M; Wate R; Kaneko S; Sasaki S; Yamane K; Suzuki N; Aoki M; Shibata N; Togashi S; Kawata A; Mochizuki Y; Mizutani T; Maruyama H; Hirano A; Takahashi R; Kawakami H; Kusaka H
    Acta Neuropathol; 2011 Apr; 121(4):555-7. PubMed ID: 21327942
    [No Abstract]   [Full Text] [Related]  

  • 4. The genetics of amyotrophic lateral sclerosis.
    Kuźma-Kozakiewicz M; Kwieciński H
    Neurol Neurochir Pol; 2009; 43(6):538-49. PubMed ID: 20054757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
    Strong MJ; Volkening K
    FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetics of amyotrophic lateral sclerosis].
    Hübers A; Weishaupt JH; Ludolph AC
    Nervenarzt; 2013 Oct; 84(10):1213-9. PubMed ID: 24072096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis.
    DeJesus-Hernandez M; Kocerha J; Finch N; Crook R; Baker M; Desaro P; Johnston A; Rutherford N; Wojtas A; Kennelly K; Wszolek ZK; Graff-Radford N; Boylan K; Rademakers R
    Hum Mutat; 2010 May; 31(5):E1377-89. PubMed ID: 20232451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroscience. All eyes on RNA.
    Garber K
    Science; 2012 Dec; 338(6112):1282-3. PubMed ID: 23224536
    [No Abstract]   [Full Text] [Related]  

  • 9. From nucleation to widespread propagation: A prion-like concept for ALS.
    Maniecka Z; Polymenidou M
    Virus Res; 2015 Sep; 207():94-105. PubMed ID: 25656065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis.
    Laferriere F; Polymenidou M
    Swiss Med Wkly; 2015; 145():w14054. PubMed ID: 25635517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
    Fiesel FC; Kahle PJ
    FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
    Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
    Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature.
    Lucchesi C; Caldarazzo Ienco E; Fabbrini M; Pasquali L; Lo Gerfo A; Fogli A; Siciliano G
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):137-139. PubMed ID: 27494151
    [No Abstract]   [Full Text] [Related]  

  • 14. New treatments in amyotrophic lateral sclerosis.
    Maragakis N; Rothstein JD
    Neuropsychopharmacology; 2011 Jan; 36(1):370-2. PubMed ID: 21116264
    [No Abstract]   [Full Text] [Related]  

  • 15. Determinants of rapid disease progression in ALS.
    Yamanaka K; Cleveland DW
    Neurology; 2005 Dec; 65(12):1859-60. PubMed ID: 16380607
    [No Abstract]   [Full Text] [Related]  

  • 16. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations.
    Millecamps S; Salachas F; Cazeneuve C; Gordon P; Bricka B; Camuzat A; Guillot-Noël L; Russaouen O; Bruneteau G; Pradat PF; Le Forestier N; Vandenberghe N; Danel-Brunaud V; Guy N; Thauvin-Robinet C; Lacomblez L; Couratier P; Hannequin D; Seilhean D; Le Ber I; Corcia P; Camu W; Brice A; Rouleau G; LeGuern E; Meininger V
    J Med Genet; 2010 Aug; 47(8):554-60. PubMed ID: 20577002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
    Kwiatkowski TJ; Bosco DA; Leclerc AL; Tamrazian E; Vanderburg CR; Russ C; Davis A; Gilchrist J; Kasarskis EJ; Munsat T; Valdmanis P; Rouleau GA; Hosler BA; Cortelli P; de Jong PJ; Yoshinaga Y; Haines JL; Pericak-Vance MA; Yan J; Ticozzi N; Siddique T; McKenna-Yasek D; Sapp PC; Horvitz HR; Landers JE; Brown RH
    Science; 2009 Feb; 323(5918):1205-8. PubMed ID: 19251627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perspective on stem cell modeling of amyotrophic lateral sclerosis.
    de Boer AS; Eggan K
    Cell Cycle; 2015; 14(23):3679-88. PubMed ID: 26505672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular approaches to amyotrophic lateral sclerosis.
    Smith RG; Appel SH
    Annu Rev Med; 1995; 46():133-45. PubMed ID: 7598450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.